EQS-News: BRAIN Biotech AG / Key word(s): 9 Month figures/Quarterly / Interim StatementBRAIN Biotech AG reports solid 9M numbers despite ongoing high R&D investments and more challenging economic conditions 30.08.2023 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.BRAIN Bi.
EQS-News: BRAIN Biotech AG / Key word(s): Half Year Results/Half Year ReportBRAIN Biotech AG stays on solid growth path with H1 results and accelerates One-BioProducts strategy 25.05.2023 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.BRAIN Biotech AG stays on solid growth path.
27.02.2023 - EQS-News: BRAIN Biotech AG / Key word(s): Quarter Results/Quarterly / Interim Statement BRAIN Biotech AG with Strong Start into Fiscal Year 2022/23, 3M Reporting 27.02.2023 / 07:30 CET/CEST The issuer is solely responsible for the content of this . Seite 1
EQS-News: BRAIN Biotech AG / Key word(s): Quarter Results/Quarterly / Interim StatementBRAIN Biotech AG with Strong Start into Fiscal Year 2022/23, 3M Reporting 27.02.2023 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.BRAIN Biotech AG with Strong Start into Fiscal Year 2022/23.